CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 85 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $495 | -50.5% | 4,479 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $1,000 | 0.0% | 4,479 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,000 | -50.0% | 4,479 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,000 | -33.3% | 4,479 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $3,000 | -40.0% | 4,479 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $5,000 | -37.5% | 4,479 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $8,000 | -11.1% | 4,479 | 0.0% | 0.01% | -14.3% |
| Q1 2021 | $9,000 | -25.0% | 4,479 | -55.1% | 0.01% | -30.0% |
| Q4 2020 | $12,000 | -33.3% | 9,980 | 0.0% | 0.01% | -37.5% |
| Q3 2020 | $18,000 | -78.6% | 9,980 | 0.0% | 0.02% | -82.6% |
| Q2 2020 | $84,000 | +61.5% | 9,980 | 0.0% | 0.09% | +46.0% |
| Q1 2020 | $52,000 | – | 9,980 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $1,273,000 | 0.73% |
| ETF MANAGERS GROUP, LLC | 7,062,485 | $1,787,000 | 0.05% |
| Ikarian Capital, LLC | 862,527 | $217,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 457,209 | $115,000 | 0.02% |
| Platform Technology Partners | 33,750 | $9,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 910,006 | $230,000 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $7,683 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,029,171 | $1,016,000 | 0.00% |
| Vident Investment Advisory, LLC | 267,612 | $67,000 | 0.00% |
| Aries Wealth Management | 15,400 | $4,000 | 0.00% |